EUVIMEDEUVIMED entdecken
Crossref

A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia

Liyan Yang, Haiyue Niu, Tian Zhang, Qiuying Cao, Mengyuan Liu, Yumei Liu, Li Yan, Weiwei Qi, Ting Wang, Chunyan Liu, Lijuan Li, Limin Xing und 3 weitere

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-05636-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Liyan Yang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, General Hospital, Tianjin Medical University, No. 154 Anshandao Road, Heping District, Tianjin, 300052, China. Hauptthemen laut MEDLINE: Cyclosporine, Red-Cell Aplasia, Pure, Nomograms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China, Tianjin Research Program of Application Foundation and Advanced Technology of China, Tianjin Municipal Science and Technology Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pure red cell aplasia (PRCA) is a rare bone marrow disorder characterized by a severe reduction or absence of erythroid precursor cells, without affecting granulocytes and megakaryocytes. Immunosuppressive therapies, particularly cyclosporine, have demonstrated efficacy as a primary treatment. This study aims to develop a predictive model for assessing the efficacy of cyclosporine in acquired PRCA (aPRCA). This retrospective study encompasses newly treated aPRCA patients at the General Hospital of Tianjin Medical University. Diagnosis criteria include severe anemia, and absolute reticulocyte count below 10 × 109/L, with normal white blood cell and platelet counts, and a severe reduction in bone marrow erythroblasts. Cyclosporine therapy was administered, with dose adjustments based on blood concentration. Response to cyclosporine was evaluated according to established criteria. Statistical analysis involved logistic multi-factor regression, generating a predictive model. The study included 112 aPRCA patients with a median age of 63.5 years. Patients presented with severe anemia (median Hb, 56 g/L) and reduced reticulocyte levels. Eighty-six patients had no bone marrow nucleated erythroblasts. Primary PRCA accounted for 62 cases (55.4%), and secondary PRCA accounted for 50 cases (44.6%). Univariate analysis revealed that ferritin, platelet to lymphocyte ratio (PLR), and CD4/CD8 ratio influenced treatment response. Multivariate analysis further supported the predictive value of these factors. A prediction model was constructed using ferritin, PLR, and CD4/CD8 ratio, demonstrating high sensitivity and specificity. The ferritin, PLR, and CD4/CD8-based nomogram showed good predictive ability for aPRCA response to cyclosporine. This model has potential clinical value for individualized diagnosis and treatment of aPRCA patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclosporineRed-Cell Aplasia, PureNomogramsHumansMiddle AgedFemaleMaleRetrospective StudiesAgedAdultImmunosuppressive AgentsTreatment OutcomeAged, 80 and over

Stichwörter der Autor:innen

Acquired pure red cell aplasiaCyclosporineFerritinLymphocytePredictive models

Substanzen

CyclosporineImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Hematology, General Hospital, Tianjin Medical University, No. 154 Anshandao Road, Heping District, Tianjin, 300052, China.
  • Department of Hematology, General Hospital, Tianjin Medical University, No. 154 Anshandao Road, Heping District, Tianjin, 300052, China. wanghuaquan@tmu.edu.cn.
  • Department of Hematology, General Hospital, Tianjin Medical University, No. 154 Anshandao Road, Heping District, Tianjin, 300052, China. shaozonghong@sina.com.
  • Department of Hematology, General Hospital, Tianjin Medical University, No. 154 Anshandao Road, Heping District, Tianjin, 300052, China. florai@sina.com.

Förderung

  • Innovative Research Group Project of the National Natural Science Foundation of China
  • Tianjin Research Program of Application Foundation and Advanced Technology of China
  • Tianjin Municipal Science and Technology Committee
  • Key Technologies Research and Development Program
  • The Zhaoyicheng Medical Science Foundation of Tianjin China

Zitieren

APA

Yang, L., Niu, H., Zhang, T., Cao, Q., Liu, M., Liu, Y., Yan, L., Qi, W., Wang, T., Liu, C., Li, L., Xing, L., Wang, H., Shao, Z., & Fu, R. (2024). A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia. Annals of Hematology. https://doi.org/10.1007/s00277-024-05636-9

Vancouver

Yang L, Niu H, Zhang T, Cao Q, Liu M, Liu Y, et al. A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia. Annals of Hematology. 2024. doi:10.1007/s00277-024-05636-9

BibTeX
@article{Yang2024,
  author = {Yang, Liyan and Niu, Haiyue and Zhang, Tian and Cao, Qiuying and Liu, Mengyuan and Liu, Yumei and Yan, Li and Qi, Weiwei and Wang, Ting and Liu, Chunyan and Li, Lijuan and Xing, Limin and Wang, Huaquan and Shao, Zonghong and Fu, Rong},
  title = {A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-05636-9}
}
Kostenlos starten →